Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Aneurysm SaC ManagemENt Device for Abdominal Aortic Aneurysms First-in-Human (ASCEND) Study

NCT07020611 is registered in ClinicalTrials.gov with Life Seal Vascular Inc. as lead sponsor.

NCT NCT07020611
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07020611 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Aneurysm SaC ManagemENt Device for Abdominal Aortic Aneurysms First-in-Human (ASCEND) Study
Lead sponsor
Life Seal Vascular Inc.
Phase
Not applicable
Overall status
Recruiting
Start date
November 26, 2025
Completion date
September 30, 2028
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

abdominal aortic aneurysm